135 related articles for article (PubMed ID: 26817955)
1. Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.
Sparkenbaugh EM; Chantrathammachart P; Chandarajoti K; Mackman N; Key NS; Pawlinski R
Blood; 2016 Mar; 127(10):1371-3. PubMed ID: 26817955
[No Abstract] [Full Text] [Related]
2. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
Front Immunol; 2020; 11():1910. PubMed ID: 32973791
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor and thrombin in sickle cell anemia.
Chantrathammachart P; Pawlinski R
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S70-2. PubMed ID: 22398014
[TBL] [Abstract][Full Text] [Related]
4. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory and oxidative stress phenotypes in transgenic sickle cell mice.
Charrin E; Ofori-Acquah SF; Nader E; Skinner S; Connes P; Pialoux V; Joly P; Martin C
Blood Cells Mol Dis; 2016 Nov; 62():13-21. PubMed ID: 27835777
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor expression in sickle cell anemia.
Hammerschmidt DE
J Lab Clin Med; 2001 Jun; 137(6):440. PubMed ID: 11388349
[No Abstract] [Full Text] [Related]
7. Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease.
Courbebaisse M; Mehel H; Petit-Hoang C; Ribeil JA; Sabbah L; Tuloup-Minguez V; Bergerat D; Arlet JB; Stanislas A; Souberbielle JC; Le Clésiau H; Fischmeister R; Friedlander G; Prié D
Haematologica; 2017 Feb; 102(2):e33-e35. PubMed ID: 27789679
[No Abstract] [Full Text] [Related]
8. Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.
Gavins FN; Russell J; Senchenkova EL; De Almeida Paula L; Damazo AS; Esmon CT; Kirchhofer D; Hebbel RP; Granger DN
Blood; 2011 Apr; 117(15):4125-33. PubMed ID: 21304105
[TBL] [Abstract][Full Text] [Related]
9. Excess of heme induces tissue factor-dependent activation of coagulation in mice.
Sparkenbaugh EM; Chantrathammachart P; Wang S; Jonas W; Kirchhofer D; Gailani D; Gruber A; Kasthuri R; Key NS; Mackman N; Pawlinski R
Haematologica; 2015 Mar; 100(3):308-14. PubMed ID: 25596265
[TBL] [Abstract][Full Text] [Related]
10. Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation.
Kaul DK; Kollander R; Mahaseth H; Liu XD; Solovey A; Belcher J; Kelm RJ; Vercellotti GM; Hebbel RP
Microcirculation; 2006 Sep; 13(6):489-97. PubMed ID: 16864415
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin.
Solovey A; Kollander R; Shet A; Milbauer LC; Choong S; Panoskaltsis-Mortari A; Blazar BR; Kelm RJ; Hebbel RP
Blood; 2004 Aug; 104(3):840-6. PubMed ID: 15073034
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Tissue Factor Regulates Inflammation, Hypertrophy, and Heart Failure in Mouse Model of Type 1 Diabetes.
Cibi DM; Sandireddy R; Bogireddi H; Tee N; Ghani SABA; Singh BK; Mackman N; Singh MK; Singh A
Diabetes; 2021 Sep; 70(9):2131-2146. PubMed ID: 34155039
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.
Zhao S; Adebiyi MG; Zhang Y; Couturier JP; Fan X; Zhang H; Kellems RE; Lewis DE; Xia Y
FASEB J; 2018 May; 32(5):2855-2865. PubMed ID: 29401601
[TBL] [Abstract][Full Text] [Related]
14. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
Zhang Y; Chen W; Wang Y
Biomed Pharmacother; 2020 May; 125():110022. PubMed ID: 32106379
[TBL] [Abstract][Full Text] [Related]
15. FXa takes center stage in vascular inflammation.
Ruf W
Blood; 2014 Mar; 123(11):1630-1. PubMed ID: 24627521
[No Abstract] [Full Text] [Related]
16. A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
Solovey A; Somani A; Belcher JD; Milbauer L; Vincent L; Pawlinski R; Nath KA; Kelm RJ; Mackman N; O'Sullivan MG; Gupta K; Vercellotti GM; Hebbel RP
Am J Hematol; 2017 Nov; 92(11):1119-1130. PubMed ID: 28699284
[TBL] [Abstract][Full Text] [Related]
17. Genetic inactivation of calpain-1 attenuates pain sensitivity in a humanized mouse model of sickle cell disease.
Nwankwo JO; Lei J; Xu J; Rivera A; Gupta K; Chishti AH
Haematologica; 2016 Oct; 101(10):e397-e400. PubMed ID: 27418647
[No Abstract] [Full Text] [Related]
18. Cardiac size and function in children with sickle cell anemia.
Balfour IC; Covitz W; Davis H; Rao PS; Strong WB; Alpert BS
Am Heart J; 1984 Aug; 108(2):345-50. PubMed ID: 6235732
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment.
Noubouossie DC; Lê PQ; Rozen L; Ziereisen F; Willems D; Demulder A; Ferster A
Eur J Haematol; 2013 Jul; 91(1):46-54. PubMed ID: 23530655
[TBL] [Abstract][Full Text] [Related]
20. A thalidomide-hydroxyurea hybrid increases HbF production in sickle cell mice and reduces the release of proinflammatory cytokines in cultured monocytes.
Lanaro C; Franco-Penteado CF; Silva FH; Fertrin KY; Dos Santos JL; Wade M; Yerigenahally S; de Melo TR; Chin CM; Kutlar A; Meiler SE; Costa FF
Exp Hematol; 2018 Feb; 58():35-38. PubMed ID: 29108926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
